1. Home
  2. PLUS vs RXRX Comparison

PLUS vs RXRX Comparison

Compare PLUS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUS
  • RXRX
  • Stock Information
  • Founded
  • PLUS 1990
  • RXRX 2013
  • Country
  • PLUS United States
  • RXRX United States
  • Employees
  • PLUS N/A
  • RXRX N/A
  • Industry
  • PLUS Retail: Computer Software & Peripheral Equipment
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLUS Technology
  • RXRX Health Care
  • Exchange
  • PLUS Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • PLUS 1.9B
  • RXRX 2.0B
  • IPO Year
  • PLUS 1996
  • RXRX 2021
  • Fundamental
  • Price
  • PLUS $68.86
  • RXRX $5.46
  • Analyst Decision
  • PLUS
  • RXRX Buy
  • Analyst Count
  • PLUS 0
  • RXRX 5
  • Target Price
  • PLUS N/A
  • RXRX $7.00
  • AVG Volume (30 Days)
  • PLUS 226.9K
  • RXRX 29.1M
  • Earning Date
  • PLUS 08-05-2025
  • RXRX 08-07-2025
  • Dividend Yield
  • PLUS N/A
  • RXRX N/A
  • EPS Growth
  • PLUS N/A
  • RXRX N/A
  • EPS
  • PLUS 4.05
  • RXRX N/A
  • Revenue
  • PLUS $2,068,789,000.00
  • RXRX $59,790,000.00
  • Revenue This Year
  • PLUS $3.88
  • RXRX $23.85
  • Revenue Next Year
  • PLUS $2.84
  • RXRX $43.06
  • P/E Ratio
  • PLUS $17.01
  • RXRX N/A
  • Revenue Growth
  • PLUS N/A
  • RXRX 29.32
  • 52 Week Low
  • PLUS $53.83
  • RXRX $3.79
  • 52 Week High
  • PLUS $106.98
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • PLUS 48.07
  • RXRX 52.97
  • Support Level
  • PLUS $69.25
  • RXRX $5.19
  • Resistance Level
  • PLUS $72.37
  • RXRX $5.88
  • Average True Range (ATR)
  • PLUS 1.88
  • RXRX 0.36
  • MACD
  • PLUS -0.43
  • RXRX 0.01
  • Stochastic Oscillator
  • PLUS 17.40
  • RXRX 47.18

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: